Middle East & Africa Breast Cancer Brachytherapy Market Size & Outlook
Middle East & Africa breast cancer brachytherapy market, 2015-2027 (US$M)
Related Markets
MEA breast cancer brachytherapy market highlights
- The MEA breast cancer brachytherapy market generated a revenue of USD 1.8 million in 2018.
- The market is expected to grow at a CAGR of 7.2% from 2019 to 2027.
- In terms of segment, high dose rate (hdr) was the largest revenue generating technology in 2018.
- High Dose Rate (HDR) is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2019 to 2027.
MEA data book summary
| Market revenue in 2018 | USD 1.8 million |
| Market revenue in 2027 | USD 3.4 million |
| Growth rate | 7.2% (CAGR from 2018 to 2027) |
| Largest segment | High dose rate (hdr) |
| Fastest growing segment | High Dose Rate (HDR) |
| Historical data covered | 2015 - 2017 |
| Base year for estimation | 2018 |
| Forecast period covered | 2019 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | High Dose Rate (HDR), Low Dose Rate (LDR) |
| Key market players worldwide | Eckert & Ziegler Bebig SA, Elekta AB ADR, Siemens Healthineers AG ADR, Icad Inc, Hologic Inc, Merit Medical Systems Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.1% of the global breast cancer brachytherapy market in 2018.
- Globally, North America is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 22.0 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Brachytherapy Market Scope
Breast Cancer Brachytherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa breast cancer brachytherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer brachytherapy market will help companies and investors design strategic landscapes.
High dose rate (hdr) was the largest segment with a revenue share of 66.67% in 2018. Horizon Databook has segmented the Middle East & Africa breast cancer brachytherapy market based on high dose rate (hdr), low dose rate (ldr) covering the revenue growth of each sub-segment from 2015 to 2027.
- Middle East & Africa Breast Cancer Brachytherapy Technology Outlook (Revenue, USD Million, 2015-2027)
- High Dose Rate (HDR)
- Low Dose Rate (LDR)
Reasons to subscribe to Middle East & Africa breast cancer brachytherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa breast cancer brachytherapy market databook
-
Our clientele includes a mix of breast cancer brachytherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa breast cancer brachytherapy market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa breast cancer brachytherapy market from 2015 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
MEA breast cancer brachytherapy market size, by country, 2015-2027 (US$M)
Middle East & Africa Breast Cancer Brachytherapy Market Share, 2018 & 2027 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
